MIP-2A
1 was identified as a MBP-1-interacting protein by screening a HeLa cDNA expression library (1) . MIP-2A localizes at human chromosome 19 and encodes an ϳ16-kDa protein. A computer search using the BLAST program matched MIP-2A with the coding sequence of the SEDL gene (1, 2); however, the SEDL gene is located at human chromosome Xp22 (2, 3) . Initially, sedlin (gene product of SEDL) was predicted by in silico cloning and assembly of overlapping expressed sequence tag sequences (2, 4) . Sedlin cDNA has recently been cloned, although the function of this gene product is yet to be known (3) . We have shown previously that MBP-1 acts as a transcriptional repressor, and MIP-2A associates with MBP-1 to relieve its repressor activity (1) . Additionally, MIP-2A antagonizes the cell growth regulatory role of MBP-1.
Pituitary gland synthesizes two gonadotropic hormones, luteinizing hormone (LH) and follicle-stimulating hormone. Both hormones are composed of a common ␣-subunit that is combined with unique ␤-subunits that dictate the biological specificity of each hormone. The human LH␤ promoter contains an SF-1 (steroidogenic factor 1) element and several consensus Ptx1-binding sites that are conserved across species (5-7). The orphan nuclear receptor SF-1 is an essential factor for mammalian sexual differentiation and endocrine organogenesis. Targeted disruption of the Ftz-F1 gene in mice, which encodes SF-1, precludes the development of endocrine organs, including the adrenals, gonads, and ventromedial hypothalamus, and leads to loss of pituitary cell types (8 -10) . Numerous cellular studies have implicated SF-1 as a mediator of cell-specific gene expression in adult endocrine organs (reviewed in Ref. 11) .
SF-1
Ϫ/Ϫ mice exhibit markedly reduced mRNA levels for several pituitary-specific genes including luteinizing hormone ␤ (12, 13) .
The Ptx family of transcription factors is a recently identified class of bicoid-related homeoproteins that are thought to be involved in the development of anterior structures and in mesoderm specification (14) . Ptx1 was cloned initially as a regulator of pro-opiomelanocortin (POMC) gene expression in pituitary corticotrope cells (15) but was later found to be a panpituitary regulator of transcription (7) . The Ptx1 transcription factor is present in all adult pituitary cells and activates transcription of a large set of pituitary target genes (7, (15) (16) (17) . Ptx1 activates the LH␤ promoter in synergy with SF-1 (7) and with the immediate early response gene product, Egr-1 (18) . Egr-1 interacts directly with Ptx1 and with SF-1, leading to an enhancement of LH␤ transcription (18) . Thus, Ptx1 appears to work in a combinatorial code to confer lineage-and promoterspecific gene transcription in the pituitary gland (14) . In this study, we observed differential expression of MIP-2A in various human tissues including pituitary gland. We demonstrated that MIP-2A acts as a coregulator of SF-1-and Ptx1-mediated activation of LH␤ gene transcription.
EXPERIMENTAL PROCEDURES
RNA Dot Blot Analysis-Human multiple tissue expression array (Clontech) was performed by RNA blot analysis according to the manufacturer's protocol to examine the MIP-2A expression. The mRNA concentration of each tissue or cells in the array was normalized by the manufacturer to yield similar hybridization signals for various housekeeping genes allowing comparative analysis of gene expression. The array blot was hybridized using the entire cDNA of MIP-2A (including a 213-bp 5Ј-noncoding sequence) labeled with [␣-32 P]dCTP (Amersham Biosciences) under high stringency. After hybridization and washing under high stringent conditions, the blot was exposed to x-ray film for autoradiography.
Cell Transfection and Reporter Gene Assay-Monkey kidney cell lines (CV1 and COS-7) were grown in Dulbecco's modified Eagle's * This research was supported by Grant CA52799 from NCI, National Institutes of Health. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. (19) . Cells were transfected with 1 g of reporter plasmid LH␤-luc (human luteinizing hormone ␤ promoter in the upstream of luciferase gene) and 0.5 g of CMV-MIP-2A and CMV-SF-1 or CMV-Ptx1 using LipofectAMINE (Invitrogen). Empty vector was used as the control in the luciferase assay. In a different experiment, cells were transfected with 1 g of 2xSF1-tk-luc (two consensus DNA-binding sequences for SF-1 upstream of the tk promoter in luciferase reporter construct) or G5E1b-luc, 0.2 g of CMV-SF-1, and different doses of CMV-MIP-2A (0.2 Ϫ2 g) using LipofectAMINE. Luciferase activity was determined after lysing the cells with reporter lysis buffer (Promega) using a luminometer (Optocomp II, MGM Instruments) as described previously (20) . The activities were normalized with respect to the protein concentration of the cell lysates.
Protein-Protein Interaction Assay-COS-7 cells were cotransfected with CMV-FLAG-Ptx1 (21) and/or CMV-HASF-1 (22) . Cell lysates were prepared after 48 h of transfection in lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1 mM EDTA, 10% glycerol, 1% Triton X-100, 0.1 mM phenylmethylsulfonyl fluoride, and a mixture of protease inhibitors). Cell extracts were clarified by centrifugation and incubated with His-MIP-2A beads at 4°C for 2 h. The beads were washed and resuspended in SDS-PAGE sample buffer. The eluted proteins were separated by SDS-12% PAGE and transferred onto nitrocellulose. The blot was probed with a mouse monoclonal antibody to FLAG for detection of Ptx1 or an antibody to HA for SF-1. Proteins were detected by enhanced chemiluminescence (Amersham Biosciences).
Immunofluorescence Study-GH 3 cells grown on glass coverslips were transfected with CMV-HASF-1 and/or CMV-FLAG-MIP-2A using LipofectAMINE. Cells were washed 48 h post-transfection and fixed with 3.7% formaldehyde in phosphate-buffered saline for 30 min. Cells were permeabilized with 0.2% Triton X-100 in phosphate-buffered saline for 5 min and washed and incubated either with a rabbit polyclonal antibody to HA-epitope or anti-FLAG mouse monoclonal antibody for 1 h at room temperature. Cells were washed and incubated with fluorochrome-conjugated secondary antibodies for 1 h at room temperature. Finally, cells were washed and mounted for confocal microscopy (BioRad 1024). Fluorescent images were superimposed digitally to allow fine comparison. Colocalization of green (Alexa 488) and red (Alexa 568) signals in a single pixel produces yellow color, whereas separated signals remain green or red. Cells did not display a detectable staining when negative control sera were used.
RESULTS

Expression of MIP-2A in Human
Tissues-We examined expression of MIP-2A using a multiple tissue expression array with mRNA from several human tissues and cell lines. MIP-2A cDNA probe containing the 5Ј-untranslated region upstream of the entire coding sequence was hybridized with a human multiple tissue array blot (Fig. 1 ). Predominant expression of MIP-2A was observed in the right cerebellum (2B), pituitary gland (3D), testis (8F), and adrenal gland (9C). Expression of MIP-2A was barely detected in the skeletal muscle (7B). Lower level expression of MIP-2A was also observed in bone marrow (7G), the bladder (8C), ovary (8G), HL-60 (10A), Burkitt's lymphoma-Raji (10E), and lung carcinoma-A549 (10H) cells. Moderate to low levels of MIP-2A expression were detected in all the other tissues. In the negative control Escherichia coli DNA (D12), a moderate hybridization signal was noted as reported earlier (23); however, no signal was detected from the other negative controls such as yeast total RNA (12A), yeast tRNA (12B), E. coli rRNA (12C), poly(rA) (12E), human C o t-1DNA (12F), human DNA (100 ng) (12G), and human DNA (500 ng) (12H). The coding sequence of MIP-2A displays identity with that of SEDL; however, the 5Ј-noncoding region differs significantly (1) . SEDL is expressed at a high level in several tissues including skeletal muscle (2, 3), whereas MIP-2A is barely detected in skeletal muscle. Therefore, this result suggested a substantial difference in expression pattern between MIP-2A and SEDL. fore, to investigate the role of MIP-2A on SF-1-mediated transactivation of the LH␤ gene, we performed an in vitro reporter gene assay using the LH␤ promoter (the 5Ј-flanking region containing Ϫ668 to Ϫ8 bp relative to the translation start site) linked to a luciferase gene (LH␤-luc). CV1 cells were cotransfected with CMV-HASF-1 and CMV-MIP-2A along with the human LH␤-luc reporter construct. Empty vector was used as a negative control. Our results suggested that SF-1 expression increased transcriptional activity of the LH␤ promoter to ϳ4-fold, which was relieved to the basal level upon coexpression of MIP-2A (Fig. 3A) . However, MIP-2A alone did not exhibit a detectable activity on the LH␤ promoter suggesting that MIP-2A can exert its inhibitory effect on SF-1-mediated transactivation of the human LH␤ promoter.
MIP-2A Inhibits SF-1-mediated Activation of the
To further verify that MIP-2A indeed modulates the SF-1-mediated activation of the LH␤ promoter, we performed an in vitro reporter assay in pituitary gonadotrope L␤T2 cells. LH␤-luc was transfected with empty vector or different doses of CMV-MIP-2A into L␤T2 cells. Luciferase activity was measured after 48 h of transfection. Our results demonstrated that MIP-2A represses LH␤ promoter activity in a dose-dependent manner (Fig. 3B) .
SF-1 activates transcription by binding its specific DNA sequence on the target gene promoter (7) . We observed that MIP-2A relieves SF-1-mediated transactivation. To determine whether the regulatory effect of MIP-2A is indeed dependent on the presence of the SF-1-responsive element, we have used a synthetic reporter plasmid with two SF-1-binding sites (2xSF1-tk-luc). CV1 or pituitary non-gonatrope cell line GH 3 (lacking endogenous SF-1) was transfected with 2xSF1-tk-luc reporter plasmid, CMV-SF-1, and CMV-MIP-2A. Luciferase activity was measured after 48 h of transfection. SF-1 expression induced about 8 -20-fold activation of the reporter gene (Fig. 3C) . On the other hand, when MIP-2A was coexpressed with SF-1, luciferase activity was inhibited to the basal level. This result further suggests that MIP-2A interferes with SF-1-dependent transactivation.
MIP-2A Interrupts Ptx1-mediated Transactivation of the Human LH␤ Promoter-Ptx1 binds to the regulatory sequences and activates most pituitary-hormone coding gene promoters including LH␤ (7, 17) . Therefore, we further investigated whether MIP-2A can interrupt Ptx1-mediated regulation of the LH␤ promoter activity in a similar in vitro reporter gene assay using LH␤-luc reporter construct. Empty vector was used as a negative control. We observed that exogenous expression of Ptx1 induces the LH␤ promoter activity (ϳ6-fold), which was repressed by MIP-2A in a dose-dependent manner (Fig. 4) . However, expression of MIP-2A alone did not have a detectable activity on the LH␤ promoter suggesting that MIP-2A also perturbs Ptx1-mediated activation of the LH␤ promoter.
MIP-2A Perturbs the Synergistic
the synergistic effect of SF-1 and Ptx1 on LH␤ promoter activation. CV1 cells were cotransfected with CMV-HASF-1, CMV-FLAGPtx1, or CMV-MIP-2A effector plasmid DNAs along with the reporter gene LH␤-luc, and luciferase assay was performed after 48 h of transfection. Empty vector was used as a negative control and to keep the amount of DNA constant in each transfection. Expression of SF-1 or Ptx1 activated the promoter by ϳ2-3-fold in a suboptimal dose (Fig. 5) . 25) . This is most likely to occur in the presence of high level endogenous SF-1 and/or Ptx1 in the gonadotrope cells. However, coexpression of SF-1 and Ptx1 enhanced the LH␤ promoter activity ϳ1.7-fold, which was repressed in the presence of MIP-2A (data not shown). These results suggested that ectopic expression of MIP-2A abrogates SF-1-and Ptx1-mediated transcriptional activation of the LH␤ gene in pituitary gonadotrope L␤T2 cells as well as in CV1 cells.
MIP-2A Interacts with SF-1 and Ptx1
-Because MIP-2A does not bind to the DNA sequence, we examined whether MIP-2A physically associates with SF-1 and/or Ptx1. For this purpose, we performed a pull-out experiment by transfecting COS-7 cells with empty vector, CMV-FLAGPtx1, or CMV-HASF-1 construct and lysed the cells 48 h post-transfection as described previously (26) . Cell lysates were then incubated with His-tag MIP-2A immobilized onto nickel beads followed by Western blot analysis using specific antibodies to detect Ptx1 or SF-1 (Fig. 6) . A specific association was detected between Ptx1 and MIP-2A (Fig. 6A, lane 2) . Similarly, MIP-2A beads retained the SF-1 protein from the cell lysates transfected with the CMV-HASF-1 plasmid DNA (Fig. 6B, lane 2) . These results suggested that MIP-2A physically interacts with both Ptx1 and SF-1. We further examined for association of MIP-2A with both Ptx1 and SF-1 in a similar pull-out experiment. COS-7 cells were cotransfected with the Ptx1 and SF-1 expression plasmid DNAs, and the cell lysates were incubated with MIP-2A beads followed by Western blot analysis using specific antibodies. Our results demonstrated that MIP-2A pulled down both Ptx1 (Fig.  6A, lane 3) and SF-1 (Fig. 6B, lane 3) from the cell lysates. The blot was stained with Amido Black to visualize the similar amount of His-MIP-2A in each lane.
MIP-2A Retains SF-1 in the Cytoplasm-Because SF-1 is a nuclear protein (27) , and MIP-2A localizes in the cytoplasm (1), the physical association of these two proteins was somewhat surprising. To address this paradox, we investigated whether MIP-2A and SF-1 colocalize intracellularly. Initially, localization of SF-1 was examined by indirect immunofluorescence in GH 3 cells (28) transiently transfected with HA-tagged SF-1 plasmid DNA. Immunofluorescent staining using a rabbit polyclonal antibody to HA epitope exhibited a distinct nuclear localization of SF-1 (Fig. 7a) . To compare the subcellular localization of SF-1 with that of MIP-2A, GH 3 cells were cotransfected with CMV HA-tagged SF-1 and CMV-FLAG-MIP-2A. After 48 h of transfection, cells were stained with a rabbit polyclonal antibody to HA epitope for SF-1 expression (Fig. 7b) and a mouse monoclonal antibody to FLAG-epitope for expression of MIP-2A (Fig. 7c) . Confocal microscopy displayed colocalization of SF-1 with MIP-2A in the cytoplasm of the cells ( Fig. 7d) . These results suggested that MIP-2A sequesters SF-1 in the cytoplasm and modulates transcriptional activation of LH␤ gene.
MIP-2A Binds to the Amino-terminal Domain of SF-1-
The DNA-binding and Ptx1-interacting domains of SF-1 are located at the amino terminus (14) . To further examine whether a DNA-binding sequence is necessary for MIP-2A-mediated repression of SF-1, a Gal4-fusion construct lacking the DNAbinding domain (29) was used in an in vitro reporter gene assay. COS-7 cells were cotransfected with the Gal4 deletion mutant of SF-1 or CMV-MIP-2A and the G5E1b-luc reporter gene. Luciferase assay was performed after 48 h of transfection. Expression of the Gal4-fusion construct of SF-1 increased the luciferase activity (ϳ4-fold) from the basal level (Fig. 8) . However, coexpression of MIP-2A did not exhibit a significant effect on SF-1-mediated transactivation of the Gal4-responsive reporter gene. This result suggests that MIP-2A may associate with the DNA-binding domain of SF-1, which is located at the amino terminus of the protein (29) . To further verify this observation, mammalian two-hybrid analysis was performed using Gal4SF-1 and MIP-2A (1). Activation of reporter gene was not detected when SF-1 and MIP-2A were cotransfected, suggesting a lack of interaction between the deletion mutant of SF-1 and MIP-2A. This result indicated that MIP-2A may bind to the amino terminus of SF-1.
DISCUSSION
In this study, we have examined the tissue-specific expression of MIP-2A and its functional implication in transcriptional regulation. MIP-2A predominantly expresses in right cerebellum, testis, pituitary, and adrenal glands. Further analysis suggests higher level expression of MIP-2A in pituitary gonadotrope cells. These cells synthesize and secrete luteinizing hormone (24) . Therefore, we investigated the functional role of MIP-2A in pituitary hormone-specific transcription and chose LH␤ as a representative. SF-1 is expressed in pituitary gonadotropes and activates the LH␤ gene transcription by binding to the SF-1 response element on the promoter (29) . On the other hand, Ptx1 is a homeobox transcription factor that also binds and regulates LH␤ promoter activity (7, 17) . The LH␤ promoter contains binding sites for Ptx1 and SF-1 that are 20 bp apart. Although each factor can enhance the LH␤ promoter activity (5-7), coexpression of both results in a synergistic activation possibly through physical interaction between Ptx1 and SF-1. In fact, physical association between SF-1 and Ptx1 has been observed (18) . We have previously shown that MIP-2A can act as a cofactor in transcriptional regulation (1) . Therefore, we investigated whether MIP-2A could modulate SF-1-and Ptx1-mediated regulation of the LH␤ promoter. Our results suggest that MIP-2A expression inhibits transactivation of the LH␤ promoter mediated by SF-1 or Ptx1. MIP-2A also suppresses the synergistic activation of the promoter mediated by SF-1 and Ptx1 when coexpressed with these transcription factors. Subsequently, our results revealed that MIP-2A directly associates with both SF-1 and Ptx1. Therefore, the inhibitory effect of MIP-2A could be the result of the formation of a complex between MIP-2A and SF-1 bound to Ptx1 or simultaneous binding of MIP-2A with SF-1 and Ptx1 through different domains like an adapter protein.
Reproduction depends on regulated expression of the LH␤ gene, and a number of transcription factors are involved in this regulation. The immediate-early Egr-1 gene product interacts directly with Ptx1 and with SF-1 leading to an enhancement of Ptx1-and SF-1-induced LH␤ transcription (18) . However, these interactions occurred independent of DNA binding of Ptx1. It is possible that a high level of Ptx1 in gonadotropes A Gal4 deletion mutant of SF-1 lacking its amino-terminal DNA-binding domain (Gal4SF-1) was used to cotransfect COS-7 cells along with a Gal4-responsive reporter gene (G5E1b-luc) and CMV-MIP-2A expression plasmid DNA in an in vitro reporter gene assay. The amount of DNA was kept constant in each transfection by adding the empty vector plasmid DNA. Luciferase assay was performed at 48 h post-transfection. At least three independent transfections were performed in each set of experiments, and relative luciferase activity is presented with standard deviation from triplicate analysis.
could serve as a ligand for activating SF-1 and is a critical partner of the Egr-1, a key downstream effector that transduces the signal from gonadotropin-releasing hormone to the LH␤ promoter (30) . The androgen receptor suppresses transcription of the LH␤ subunit gene by interacting with SF-1 (25) . Besides LH␤ regulation, a number of transcription factors are reported to regulate SF-1 target genes by protein-protein interaction. Our present data have shown that SF-1-mediated transcription of 2xSF1-tk promoter is down-regulated by MIP-2A. DAX-1, an orphan nuclear receptor, directly interacts and inhibits transcriptional activity of SF-1, which regulates expression of multiple steroidogenic enzymes and other genes involved in reproduction (29, (31) (32) (33) . DAX-1 is predominantly expressed in adrenal gland and testis, and mutations in DAX-1 strongly affect the development of these tissues (34) . Sp1 and SF-1 interact with each other and cooperate to regulate the basal activity of the human steroidogenic acute regulatory protein (StAR) promoter, a downstream target gene of SF-1 (35) . Similarly, RIP140 modulates transcription of StAR gene through interactions with both SF-1 and DAX-1 (36) . We have also shown that MIP-2A represses LH␤ promoter activity in pituitary gonadotrope L␤T2 cells where SF-1 is expressed. These results suggest that MIP-2A may associate with endogenous SF-1 thereby modulating the LH␤ promoter activity. We demonstrated that when the DNA-binding domain of SF-1 is replaced with Gal4 DNA-binding domain, MIP-2A did not regulate SF-1-mediated transcriptional activation, suggesting that MIP-2A is likely to be associated with the amino-terminal sequences of SF-1. We have also shown that MIP-2A sequesters SF-1 in the cytoplasm. Therefore, a decrease of SF-1 in the nucleus may, in turn, affect the activation of SF-1-mediated gene expression. Taken together, our study suggests that MIP-2A preferentially expresses in certain hormonal tissues and can act as an adapter-like protein or a cofactor in modulation of gene transcription.
A growing number of evidence suggests that SF-1 regulates its target genes by interacting with a number of transcription factors, and MIP-2A is a new addition to this list. A higher level expression of MIP-2A in pituitary gonadotropes also suggests that MIP-2A may be involved in gonadotrope-specific transcriptional regulation. SF-1 regulates the expression of most steroidogenic enzymes in both female and male gonads and the adrenal cortex as well as other proteins relevant to reproductive development and function (11, 37) . Importantly, SF-1 is essential for reproductive development, because mice deficient in this transcription factor lack gonads and adrenal glands. This consequently leads to persistence of mü llerian structures even in male embryos as well as early neonatal death from adrenal insufficiency (9, 10, 13) . SF-1-deficient mice also have impaired development of the hypothalamic ventromedial nucleus (38) . Interestingly, MIP-2A also expresses predominantly in adrenal gland and testis tissues. Therefore, further studies may help to understand whether targeted inactivation of the MIP-2A gene in the animal model plays a role in the regulation of LH␤ gene.
